INTRODUCTION
In inhalation exposure to chromate compounds, an increased risk of respiratory cancer in man has been epidemiologically documented.1-4) Biochemical characteristics of chromium(VI) are easy penetration through biological membranes5,6) and subsequent intracellular reduction to chromium(III) species.6-8) Soluble chromate components deposited on the alveolar surface easily penetrate the cell membranes and are reduced to chromium(III). The intracellular reduction is a prerequisite for the appearance of the genetic action of chromate8) Microsomal electron transport systems9-11) with NADPH and NADH, certain hem proteins and flavoenzymes,12) ascorbic acid,13-16) glutathione15,17) and other cellular thiols15) have been demonstrated to be involved in biological reduction. Connett and Wetterhahn15) have investigated in vitro reduction of chromium(VI) by cellular components and concluded that the significant reactive species for the reduction of chromate in the cell cytoplasm are expected to be glutathione, cysteine and ascorbic acid. Both GSH and AsA are the most abundant reducing components existing in cells. It is important to investigate the chromium(VI)-reducing activities of mixed systems of these reductants. Few studies have been carried out on this problem. Our previous in vitro and in vivo experiments18) have revealed that the reducing ability of AsA is markedly higher than that of GSH, and that both reductants cooperate in the reduction of chromium(VI). The present paper deals with further studies of AsA-GSH cooperative reducing activity and describes the synergism that both reductants show in the reduction of chromium(VI) in vitro. Reagents, stock and standard solutions Sodium chromate tetrahydrate of analytical-reagent grade was purchased from J. T. Baker (Phillipsburg, NJ, U.S.A.) and a stock solution of 2 mM chromium(VI) was prepared with distilled water. L-Ascorbic acid, GSH and GSSG of reagent grade were purchased from Sigma (St. Louis, MO, U. S. A.). Twenty millimolar {1, 3-bis (tris(hydroxymethyl)methylamino) propane} (bis-tris propane or BTP) buffer, pH 7.4-7.8 was prepared using distilled water. All test solutions and standard solutions for reduction studies were prepared using BTP bufer. The use of BTP buffer was based on the results from a preliminary stability test showing that AsA and GSH were most stable in this buffer compared with other buffers tested (HEPES, phosphate and Tris). Stock solutions (10-40 mM) of L-AsA, GSH andGSSG were prepared daily by dissolving the reagents in BTP buffer (pH 7.4), and kept ice-cold. The standard solutions for the determination of these substances as well as chromium(VI) were prepared in the same manner. In preparing high concentrations of the reductants, buffers of higher pH were used to obtain the final pH of 7.4.
Preparation of AsA and/or GSH solutions for reduction test
Dilute solutions of L-AsA (0.02-2 mM) or GSH (2 mM) and mixed solutions of 2 mM GSH containing the above concentrations of L-AsA for reduction stuties were prepared by addition of stock solutions into BTP buffer. When preparing high concentrations of the reductant(s), buffers of higher pH were used to obtaine the final pH of 7.4. where k is the rate constant of the first-order kinetic equation. Reduction of chromium(VI) in L-AsA or GSH solution In the solutions of higher concentrations of AsA (Fig. 2) , the redox processes were pseudo-first-order in a single phase with respect to chromium(VI), as described in the previous paper.18) The half-life of chromium(VI) depended on the initial level of the reductant. In other samples containing 0.2 and 0.6 mM L-AsA (not shown), the half-life values of chromium(VI) were 7.62 and 2.99 min, respectively. In the AsA solutions of lower concentrations (0.02 and 0.05 mM) pseudo-first-order processes appeared only in initial short duration, because of the effect of AsA depletion.
The reduction of chromium(VI) in the GSH solution was characterized by two phases. The first phase (P-I) was of very short duration. The order of reaction in this phase was not clear. The apparent half-life of chromium(VI) was 9.2 min. In this phase, chromium(VI) concentration decreased by only 7% of the initial level. This phase seemed to be related to the formation of a chromium(VI) thioester.15) The second phase (P-II) was the main process of the reduction and showed pseudo-first-order kinetics, but the reaction rate was markedly slower than that in the first phase. A comparison of the half-life of chromium(VI) in the L-AsA solution of 2 mM with that in the GSH solution indicates that the reducing ability of AsA is marlrprIly hiorhPr than that of (ICH Reduction of chromium(VI) in mixed solution of L-AsA and GSH Reducing activities for chromium(VI) in mixed solutions of 2 mM GSH containing 0.02, 0.05, 0.1, 0.2, 0.6 and 2 mM L-AsA were investigated. As seen in Fig. 3 , the mixed solutions containing higher AsA levels showed pseudo-firstorder processes in a single phase with respect to chromium(VI). The two-phase reducing behavior characterized in the solution of 2 mM GSH (Fig. 2) was not observed. The sample with the lowest L-AsA level showed a reduction process composed of two phases. Depletion of AsA was responsible for the appearance of the latter phase.
In comparison with the reduction of chromium(VI) by GSH alone shown in Fig. 2 , the reduction processes in the mixed solutions revealed that the coexistence of even a small amount of AsA markedly accelerated the GSH-induced reduction. The reduction rates in the mixed solutions containing small amounts of AsA correponding to 1 and 10% of the GSH level were 27 and 77 times that in the main phase of the GSH-induced reduction process, respectively. Conversely, in mixed solutions containing high L-AsA levels and low levels of GSH, no significant effect was observed.
Synergism of L-AsA and GSH in the reduction of chromium(VI) Figure 4 shows time-related increases of chromium(III) resulting from the reduction in 0.02 mM L-AsA and 2 mM GSH solutions, as well as that in a Each point represents the mean of two or three measurements.
mixed solution of these concentrations of both reductants. This figure also includes a synthetic curve (dotted line) drawn by plotting the totals of resulting chromium(III) in both the single-reductant solutions against reaction time. The amounts of chromium(III) in the mixed solution were clearly larger than the total amounts given by the synthetic curve, especially in the earlier part of the process. At 10, 20 and 60 min, the amounts of chromium(III) in the mixed solution were 2.6, 2.3 and 1.5 times larger than those shown by the synthetic curve, respectively. Similar observations were obtained (not shown) for the mixed solutions of higher AsA concentrations and 2 mM GSH. Thus the mixed solutions of these reductants showed synergism in the reduction of chromium(VI), especially in earlier stages of the reaction. 
DISCUSSION
This experiment represented further research on chromium(VI) reduction in mixed solutions of L-AsA and GSH, at physiological pH. Unlike the previous experiment18) which included reduction studies in mixed solutions of equimolar L-AsA and GSH, the present experiment studied the reduction in mixed solutions of 2 mM GSH containing different concentrations of L-AsA. The results (Figs. 4  and 5) indicate that the mixed solutions show synergism in the reduction of chromium(VI), especially in earlier stages of the processes and that the synergistic effect is more remarkable at lower concentrations of AsA.
Glutathione and AsA are typical soluble reductants in biological systems. The present results suggest that although AsA posseses higher reducing ability than GSH, the coexistence of both the reductants is of importance for the biological reduction of chromium(VI) because of their synergism. In order to elucidate the mechanism of this synergism, further studies including the measurement of dehydroascorbic acid, oxidized glutathione, and probably further-oxidized materials of the reductants are necessary. The concentrations of the reductants used here were decided on the basis of the reported levels of AsA20,21 and GSH22,23) in the lungs of rats. These data suggest that the cytoplasmic levels of these reductants in the rat lung are in the region of 2 mM. Although biological levels of these reductants vary with difffrent species and organs, the present levels are probably within the biological region of the cytoplasm levels of both reductants.
A number of biochemical constituents15) have possible relation to the intracellular reduction of chromium(VI). However, the reduction rates of chromium(VI) in soluble fractions prepared from rat lungs have been shown to be only slightly higher than those in laboratory-prepared mixed solutions containing the same concentations of L-AsA and GSH.18) This suggests that the reducing ability of the other constituents is minor. On the other hand, since oxgen tension is critical for microsomal chromium(VI) reduction.11) it is unclear to what extent the enzymatical chromium(VI)-reducing ability of microsomes9,10) contributes to the intracellular reduction of chromium(VI). The synergism of AsA and GSH is therefore considered to contribute exclusively to the intracellular reduction of chromium (VI) .
The appearence of the genetic action of chromium(VI) depends on the reduction to the trivalent species.8) The site where the reduction occurs is of the utmost importance for the subsequent genetic action. Only when chromium(VI) is reduced inside the nucleus, genetic effects would be produced as a result of its oxidizing power and/or the formation of DNA complexes involving resulting chromium(III).8) In the alveolar lining fluids of the rat16,24,25) and guinea pig, 25) there exist considerable amounts of AsA. The reducing ability of this extracellular AsA16) protects the cells to a great extent from the penetration of chromate anions. The epithelial lining fluid of the human lower respiratory tract contains high levels of reduced glutathione.26) However, there are no available data on AsA levels in human alveolar lining fluid. Unless AsA exists there, the lower ability of GSH alone for the extracellular reduction of chromium(VI) would result in the trans-membrane penetration of most of soluble components of chromium(VI) compounds deposited in the human lung. However, when sufficient levels of AsA and GSH are maintained in the cytoplasm, the chromate anions penetrating the cells would be immediately reduced. Humans lack the ability to biologically synthesize AsA and if are deficient in this vitamin due to some disturbance, such as low intake, stress27) and smoking,28,29) soluble chromates of chromium(VI) compounds deposited in the lung could easily enter the nuclei of the cells. Sufficient intake of this vitamin would ensure the health maintenance of workers facing the risk of chromium(VI) inhalation. 
